KELSIE WATSON: Open Payments
NPI 1376097329 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 11 payments from 9 companies in 2025. Trend: 2023 $761 · 2024 $1,004 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| ABBVIE INC. | 1 | $22 |
| Medtronic, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
| HEARTFLOW, INC. | 1 | $17 |
| Abbott Laboratories | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
Products named: LEQVIO, VRAYLAR, INCEPTIV, MOUNJARO, FFRct, FREESTYLE LIBRE 3, Kerendia, SHINGRIX.
Industry payments across MO — which companies pay providers there.
